Dr Piya Paul Mudgal
Additional Professor
Manipal Institute of Virology
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
1. Principal Investigator
“Advancing Pandemic Preparedness: Innovative Multidisciplinary Strategies for COMBATing Severe Dengue”, funded by DBT, Govt. of India
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Biosafety, Biosecurity and Bioethics | 1st semester |
| Emerging viral diseases and public health response | 2nd semester |
| Viral vaccines and antiviral pharmacotherapy | 3rd semester |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| PhD | Pharmaceutical Sciences (Pharmacology) | Manipal College of Pharmaceutical Sciences | 2012 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| Manipal Institute of Virology | Additional Professor | 2026-Present | |
| Manipal Institute of Virology | Associate professor | 2020-2025 | |
| Manipal Institute of Virology | Assistant Professor | 2015-2020 | |
| Manipal Institute of Virology | Research Scientist | 2012-2015 | |
| Krupanidhi College of Pharmacy, Bangalore | Lecturer | 2007-2008 |
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Preclinical research in areas such as antiviral drug discovery and development from herbal and synthetic sources, immunomodulatory mechanisms of virus like particles, radioprotection, cancer, and metabolic disorder
Area of Expertise
Conventional Polymerase chain Reaction (PCR), gel extraction, PCR product purification, plasmid isolation, Western blotting, cell culture-based antiviral screening assays; bacterial transfection and transformation | Expertise in preclinical in vivo experiments, cannulation of Portal vein, Thoracic vein and Bile duct | Instruments handled: High Performance Liquid chromatography (HPLC), Flow Cytometer, Conventional PCR, Gel electrophoresis, Nanodrop, Biosafety Cabinet Class II | In silico drug screening using Schrödinger Molecular Docking Software
Professional Affiliations & Contributions
- Indian patent on “Innovative, inexpensive and viable method for the isolation of novel antioxidant flavonoids from the weed, Coronopus didymus Linn.”
- Presented research work in various conferences of national and international repute, organized by professional societies such as World Congress on Drug Discovery, Society for Free Radical Research, Indian Pharmaceutical Congress, Indian Pharmacological Society, Manipal McGill Center for Infectious Diseases, etc.
- Life Member, Indian Virological Society (L.M. 137/IVS/2017)
- Recipient of Global Virus Network Rising Star Mentorship Program 2021-2022
- Professional Certification in Biorisk Management, International Federation of Biosafety Associations (IFBA).
- Certification in Biosecurity, Manipal Institute of Virology and Prasanna School of Public Health, MAHE.
- Certified Internal Auditor by Suprabha Quality Solutions Internal Auditors Training on QMS (ISO 9001:2015) and EMS(ISO14001:2015).
- Certified in ‘Quality Management Systems and Internal Audit in Medical Laboratories as per ISO 15189:2012’.
- Certification in “COVID-19 vaccination training for health workers”, online training module by World Health Organization in collaboration with UNICEF.
For full publication list click here
1. Exploration of in vitro antiviral and in vivo immunomodulatory effects of a few selected phenolic phytoconstituents; Rithu Paul Stansilaus, 2015
2. In vitro Anti-Adenoviral Screening of Kaempferol; Aparna Damodaran, 2016
3. Phenotypic and genotypic characterization of Herpes Simplex Virus clinical isolates for acyclovir resistance - a retrospective study; Raksha Vikas, 2017
4. Exploring the antivirals for Chikungunya Virus (insilico and invitro approaches); Shreemadhu Bhatt, 2018
5. Identifing inhibitors of Influenza endonuclease for anti-influenza activity-in silico and invitro approach; K Sai Disha, 2019
6. Repurposing target-specific antivirals against Dengue virus; Rashmi, 2019
7. Identifying inhibitors of Japanese Encephalitis Virus using online molecular docking tools; Shaun Joe, 2020
8. Antiviral Susceptibility of Chemical Compound against Herpes Simplex Virus-1 and Influenza A H1N1 (pdm 09) Virus, Harisha R, 2021
9. Determination of Antibacterial and Antiviral Potential of Polyphenol Stabilized Copper Nanoparticle Coated Materials against Respiratory Pathogens, Amal George, 2022
10. Determination of Antibacterial and Antiviral Potential of Polyphenol Stabilized Copper Nanoparticle Coated Materials, Aiswarya P H, 2022
11. Determination of antiviral efficacy of BARRIER90 against Adenovirus type 1 and Enterovirus-Coxsackie B1, Bommana Chanakya, 2023
12. Novel and potential Neuraminidase inhibitors against Influenza A(H1N1) virus: In vitro approach, Sneha S, 2023
13. Screening of potential RdRp inhibitors through cell-based dual luciferase reporter assay, Urmila K, 2024
14. Cytokine modulations in the serum samples of dengue-infected patients in India (2019-2022), Ishika Nepali, 2024
15. Repurposing selected antivirals against dengue virus – An in vitro study, Nidhi Pandey, 2024
16. Repurposing existing antivirals for Chikungunya virus : an in-vitro analysis. Sejal Gautam, 2025
17. Prevalence and Characterization of Acyclovir-resistant Herpes simplex viruses: a retrospective study, Sneha S Lal, 2025
18. Phenotypic Characterization of Acyclovir Resistance in Thymidine Kinase Mutant Herpes Simplex Virus Isolates and Its Association with Clinical Parameters: A Retrospective Study, Saranya Muthumaran, 2026
19. Cloning and Characterization of HIV-1 Env Pseudoviruses from Neutralization-Sensitive Isolates, L.K.Monavarshini, 2026